Hyperlipidemia Prescription Drugs Market is anticipated to grow at a significant CAGR during the forecast period. Hyperlipidemia is termed as excessive building up of abnormal amounts of fats or lipids in the blood. The two common forms of lipids found in the blood include triglycerides and cholesterol. People with abnormal or unhealthy levels of blood […]
Category Archives: Pharmaceuticals
Hip Osteoarthritis Pain Drug Market is anticipated to grow at a significant CAGR during the forecast period. The common symptoms of hip osteoarthritis include pain around groin area of the hip (area between the upper thigh and lower abdomen). Generally, this pain starts gradually and gets worsen over time if not treated on time. The […]
Echinacea supplements market is anticipated to grow at a significant CAGR during the forecast period. Echinacea belongs to a class of flowering plants in the daisy family and a common herbal ingredient in cold remedies. The supplements of echinacea are perceived to boost the immune system and also support to reduction of symptoms of infections and […]
Colon cleanse market is anticipated to grow at a significant CAGR during the forecast period. Colon cleanse as the name suggests are the categories of drugs that aim at the cleansing of colon, recommended specifically for the patients undergoing colonoscopy. The market growth is attributable to the growing prevalence of colorectal cancer which primarily needs […]
Pulmonary drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to fuel the market growth include a rise in the prevalence of chronic diseases such as bronchitis, tuberculosis, and chronic obstructive pulmonary disease and a rise in tobacco smoking. Pulmonary drug delivery systems deliver […]
US Peripheral Neuropathy Treatment Market is estimated to grow at a CAGR of 4.6% during the forecast period. Significant rise in the prevalence of diabetes is the major factor accelerating the demand for peripheral neuropathy treatment in the US. As per the American Diabetes Association, in 2018, 34.2 million Americans, or 10.5% of the population, […]
North American peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.2% during the forecast period. A significant rise in cancer incidences and increasing prevalence of diabetes are some pivotal factors encouraging market growth. As per the World Health Organization (WHO), in 2018, the number of new cancer incidences reported in North […]
Indian peripheral neuropathy treatment market is estimated to grow at a CAGR of 5.8% during the forecast period. The rising prevalence of diabetes is a major factor in accelerating market growth. As per the International Diabetes Federation (IDF), In India, the total cases of diabetes in adults were nearly 77 million in 2019. The most […]
European peripheral neuropathy treatment market is estimated to grow at a CAGR of 3.8% during the forecast period. A significant rise in the prevalence of diabetes is resulting in an increasing demand for peripheral neuropathy treatment in the region. As per the International Diabetes Federation (IDF), in 2019, an estimated 59 million adults (20-79 years) […]
Asia-Pacific peripheral neuropathy treatment market is estimated to grow at a CAGR of 5.1% during the forecast period. Rising incidences of diabetes is the major factor accelerating market growth. As per the Asian Diabetes Prevention Initiative, 60% of the diabetic population across the globe live in Asia. In China, total cases of diabetes in adults […]